Benlysta Approved (Finally) for SLE - Pathophilia
Links shared publicly online about this topic.
- 449total visits
Benlysta Approved (Finally) for SLE - Pathophilia
View full resource at bmartinmd.com
Tags: Lupus, Systemic Lupus Erythematosus
Most Recently Shared on March 10, 2011 at 5:47 pm By:
Benlysta Approved (Finally) for SLE: I wrote about the "Belimumab Buzz" as a top 10 story of 2009. Now, some 14 ... http://bit.ly/gHqkEs
FDA approves Benlysta for SLE, Horizant for RLS - - Drug Topics
drugtopics.modernmedicine.com — “Systemic lupus erythematosus is a serious, potentially fatal autoimmune disease that affects between 300,000 to 1.5 million Americans of all races. Restless legs syndrome is a disruptive neurologic disorder that affects up to 10% of all Americans.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on August 14, 2011 at 4:24 pm By:
FDA approves Benlysta for SLE, Horizant for RLS: Systemic lupus erythematosus is a serious, potentially fatal au... http://t.co/w7lzkW8
FDA approves Benlysta for SLE, Horizant for RLS - - Drug Topics
drugtopics.modernmedicine.com — “Systemic lupus erythematosus is a serious, potentially fatal autoimmune disease that affects between 300,000 to 1.5 million Americans of all races. Restless legs syndrome is a disruptive neurologic disorder that affects up to 10% of all Americans.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on August 13, 2011 at 4:09 am By:
Drugs and Devices OW OW Health
FDA approves Benlysta for SLE, Horizant for RLS: Systemic lupus erythematosus is a serious, potentially fatal au... http://t.co/2yvpXCZ
Glaxo's Revolutionary Lupus Treatment Benlysta Now EU Approved - QualityPoint Technologies
qualitypointtech.net — “The first treatment developed for lupus in over 50 years has finally been approved by the European Union this week. The watchdog, European Medicines Agency, has backed the injectable drug that will cost Europeans $23,000 USD a year. Already approved in the United States in March 2011, the drug costs Americans $35,000 USD annually. Benlysta's annual global sales are expected to reach $3.55 billion in 2015, according to Thomson Reuters Pharma consensus forecasts. Some analysts predict sales as hig” View full resource at qualitypointtech.net
Most Recently Shared on July 15, 2011 at 8:00 pm By:
Glaxo's Revolutionary Lupus Treatment Benlysta Now EU Approved: The first treatment developed for lupus in over 5... http://bit.ly/mU34gW
Glaxo's Revolutionary Lupus Treatment Benlysta Now EU Approved
medicalnewstoday.com — “The first treatment developed for lupus in over 50 years has finally been approved by the European Union this week. The watchdog, European Medicines Agency, has backed the injectable drug that wi” View full resource at medicalnewstoday.com
Most Recently Shared on July 15, 2011 at 6:05 pm By:
Hisham Rana, MD Doctor and Physician
News: Glaxo's revolutionary lupus treatment Benlysta now EU approved http://bit.ly/qwZ9ly - #health #pharma
Benlysta – The FDA approved it, but is it right for me? | S.L.E. Lupus Foundation
lupusny.org — “Benlysta – The FDA approved it, but is it right for me? | S.L.E. Lupus Foundation” View full resource at lupusny.org
Most Recently Shared on June 22, 2011 at 3:16 pm By:
The FDA approved Benlsyta, the first drug indicated for #lupus in over 55 years! But is it right for you? Get answers! http://ow.ly/5nPrF
FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus
news-medical.net — “Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has approved BENLYSTA® (belimumab) for the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy.” View full resource at news-medical.net
Most Recently Shared on March 10, 2011 at 6:11 am By:
FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus: Human Genome Sciences, Inc... http://bit.ly/fFkf7V
Benlysta approved:good news 4 patients w/ mild SLE, joint,skin problems despite prednisone plaquenil and MTX,AZA or MMF http://bit.ly/gTKKNF
hgsi.com — “Benlysta approved:good news 4 patients w/ mild SLE, joint,skin problems despite prednisone plaquenil and MTX,AZA or MMF http://bit.ly/gTKKNF” View full resource at hgsi.com
Most Recently Shared on March 10, 2011 at 1:06 am By:
Lupus Doctor Physician, Doctor, Internist, and Rheumatologist
Benlysta approved:good news 4 patients w/ mild SLE, joint,skin problems despite prednisone plaquenil and MTX,AZA or MMF http://bit.ly/gTKKNF
Medical News: FDA Approves New Lupus Drug - in Rheumatology, Lupus from MedPage Today
medpagetoday.com — “The FDA has approved belimumab (Benlysta) for reducing disease activity in systemic lupus erythematosus (SLE), making it the first new lupus drug in more than 50 years.” View full resource at medpagetoday.com
Most Recently Shared on March 9, 2011 at 11:13 pm By:
FDA Approves New Lupus Drug http://bit.ly/eGbK1w
GlaxoSmithKline And Human Genome Sciences Announce FDA Priority Review Designation For Benlysta (belimumab) - QualityPoint Technologies
qualitypointtech.net — “GlaxoSmithKline PLC (GSK) and Human Genome Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted a priority review designation to Benlysta (belimumab) as a potential treatment for systemic lupus erythematosus (SLE). A priority review designation is granted to drugs that, if approved, offer major advances in treatment or provide a treatment where no adequate therapy exists. The FDA has assigned belimumab a Prescription Drug User Fee Act (PDUFA) target date of 9 Dec” View full resource at qualitypointtech.net
Most Recently Shared on August 21, 2010 at 12:51 pm By:
GlaxoSmithKline And Human Genome Sciences Announce FDA Priority Review Designation For Benlysta® (belimumab): Gla... http://bit.ly/bKAZnD
Advertisement
